What Researchers Did
Researchers treated 35 patients suffering from complex regional pain syndrome (CRPS) using a combination of hyperbaric oxygenation (HBO) and a medication called caffetin.
What They Found
All 35 patients experienced a significant decrease in pain after treatment, with pain intensity diminishing according to a visual analogous scale. The study noted considerable improvement in autonomic disorders and a reduction in anxiety and depression symptoms. Importantly, the positive effects of HBO therapy lasted for 6 months in 87% of the patients.
What This Means for Canadian Patients
For Canadian patients living with complex regional pain syndrome, these findings suggest that hyperbaric oxygen therapy could be a beneficial treatment option for managing pain and associated symptoms. The sustained pain relief observed in a high percentage of patients indicates a potential long-term benefit for improving quality of life. This offers hope for those seeking effective therapies beyond standard pain management.
Canadian Relevance
This study was not conducted by Canadian authors or in Canada. Complex Regional Pain Syndrome is not a Health Canada-recognized indication for hyperbaric oxygen therapy. Therefore, no direct Canadian connection identified.
Study Limitations
The study was published in 1997 and involved a relatively small number of patients, which limits the generalizability of its findings.